Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) EPS (Weighted Average and Diluted) (2016 - 2025)

HealthLynked (HLYK) has disclosed EPS (Weighted Average and Diluted) for 10 consecutive years, with -$0.3 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 57.14% to -$0.3 in Q3 2025 year-over-year; TTM through Sep 2025 was $0.39, a 155.71% increase, with the full-year FY2024 number at -$0.02, down 419.44% from a year prior.
  • EPS (Weighted Average and Diluted) was -$0.3 for Q3 2025 at HealthLynked, down from -$0.0 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.69 in Q4 2024 to a low of -$0.7 in Q3 2024.
  • A 5-year average of -$0.02 and a median of -$0.01 in 2022 define the central range for EPS (Weighted Average and Diluted).
  • Biggest YoY gain for EPS (Weighted Average and Diluted) was 6800.0% in 2024; the steepest drop was 6900.0% in 2024.
  • HealthLynked's EPS (Weighted Average and Diluted) stood at -$0.01 in 2021, then grew by 0.0% to -$0.01 in 2022, then surged by 200.0% to $0.01 in 2023, then surged by 6800.0% to $0.69 in 2024, then crashed by 143.48% to -$0.3 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's EPS (Weighted Average and Diluted) are -$0.3 (Q3 2025), -$0.0 (Q2 2025), and -$0.0 (Q1 2025).